Trial Profile

Study of OTSA101 in patients with Synovial Sarcomas

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 28 Mar 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs OTSA 101-Y 90 (Primary)
Indications Synovial sarcoma
Focus Adverse reactions
Sponsors OncoTherapy Science

Most Recent Events

28 Mar 2016 New trial record
23 Mar 2016 According to OncoTherapy media release, company is planning to initiate this trial for the new drug application in Japan, USA and EU.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com